cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Pliant Therapeutics Inc
6 own
4 watching
Current Price
$16.39
$-0.15
(-0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,342.95M
52-Week High
52-Week High
31.82000
52-Week Low
52-Week Low
12.60500
Average Volume
Average Volume
0.2M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,342.95M
icon52-Week High31.82000
icon52-Week Low12.60500
iconAverage Volume0.2M
iconDividend Yield--
iconP/E Ratio--
What does the Pliant Therapeutics Inc do?
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Read More
How much money does Pliant Therapeutics Inc make?
News & Events about Pliant Therapeutics Inc.
Tickeron - Stocks
8 months ago
PLRX's total volume now sits at 3M. The +-0.82% price change was insignificant, leaving IBM's price at $18.11...
Globe Newswire
8 months ago
Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitisSOUTH SAN FRANCISCO, Calif., June 23, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing ...
Globe Newswire
10 months ago
FVC Change from Baseline over 24 Weeks: ITT Population | ITT Population- SoC Subgroup Figure 1. Change in FVC from Baseline of Bexotegrast 320 mg Over 24 Weeks Figure 2. Proportion of Patients with FVC Change from Baseline of Bexotegrast 320 mg Over 12 and 24 Weeks versus Placebo - Intent to ...
Globe Newswire
10 months ago
SOUTH SAN FRANCISCO, Calif., April 12, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that Bernard Coulie, M.D., Ph.D., Pliants President...
InvestorPlace
11 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio. The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Frequently Asked Questions
Frequently Asked Questions
What is Pliant Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Pliant Therapeutics Inc shares?
plus_minus_icon
How can I buy Pliant Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Pliant Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Pliant Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Pliant Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Pliant Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Pliant Therapeutics Inc?
plus_minus_icon
What percentage is Pliant Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Pliant Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$16.39
$-0.15
(-0.91%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00